Drug Approval | November 22, 2023
Lupin receives approval from USFDA for Pitavastatin Tablets
Pitavastatin Tablets are indicated as an adjunct to diet to reduce low-density lipoprotein cholesterol
Pitavastatin Tablets are indicated as an adjunct to diet to reduce low-density lipoprotein cholesterol
The company expects that this development could improve the strength of its application to the FDA for new drug approval
Three block copolymers added to RESOMER portfolio of bioabsorbable polymers
Bains has stepped down from his role on the Biocon Board as an Independent Director with immediate effect
The super-resolution optical technology will accelerate discovery in biomedical research and transform in vitro diagnostics
Ryan has nearly 20 years of global legal and IP expertise in the pharmaceutical industry
Piramal Pharma plans to offer fully paid-up equity shares through a rights issue to its existing eligible shareholders
The addition of these two hospitals will provide increased access to specialized pediatric and perinatal care services in the geography
CiRA, Kyoto University and Astellas - Second Phase Joint Research Agreement Signed for Medical Applications of iPS Cells
Olanzapine Orally Disintegrating Tablets are used to treat certain mental/mood conditions
Subscribe To Our Newsletter & Stay Updated
